Thrombosis in cancer: Research priorities identified by a national cancer institute/national heart, lung, and blood institute strategic working group

Nigel S. Key, Alok A. Khorana, Nigel Mackman, Owen J.T. McCarty, Gilbert C. White, Charles W. Francis, Keith R. McCrae, Joseph S. Palumbo, Gary E. Raskob, Andrew T. Chan, Anil K. Sood

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

The risk for venous thromboembolism (VTE) is increased in cancer and particularly with chemotherapy, and it portends poorer survival among patients with cancer. However, many fundamental questions about cancer-associated VTE, or Trousseau syndrome, remain unanswered. This report summarizes the proceedings of a working group assembled by the NCI and NHLBI in August 2014 to explore the state of the science in cancer-associated VTE, identify clinically important research gaps, and develop consensus on priorities for future research. Representing a convergence of research priorities between the two NIH Institutes, the workshop addressed epidemiologic, basic science, clinical, and translational issues in cancer-associated VTE.

Original languageEnglish (US)
Pages (from-to)3671-3675
Number of pages5
JournalCancer Research
Volume76
Issue number13
DOIs
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Thrombosis in cancer: Research priorities identified by a national cancer institute/national heart, lung, and blood institute strategic working group'. Together they form a unique fingerprint.

  • Cite this

    Key, N. S., Khorana, A. A., Mackman, N., McCarty, O. J. T., White, G. C., Francis, C. W., McCrae, K. R., Palumbo, J. S., Raskob, G. E., Chan, A. T., & Sood, A. K. (2016). Thrombosis in cancer: Research priorities identified by a national cancer institute/national heart, lung, and blood institute strategic working group. Cancer Research, 76(13), 3671-3675. https://doi.org/10.1158/0008-5472.CAN-15-3100